[1] Ueland T, Gullestad L, Nymo SH, et al. Inflammatory cytokines as biomarkers in heart failure[J]. Clin chim acta, 2015, 443:71-77. [2] Damas JK, Smith C, Oie E, et al. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis:possible pathogenic role in plaque destabilization[J]. Arterioscler Thromb Vasc Biol, 2007, 27(3):614-620. [3] Halade GV, Jin YF, Lindsey ML. Matrix metalloproteinase (MMP)-9:a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation[J]. Pharmacol Ther, 2013, 139(1):32-40. [4] Lindsey ML, Zamilpa R. Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction[J]. Cardiovasc Ther, 2012, 30(1):31-41. [5] Li X, Li F, Chu Y, et al. NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice[J]. Cell Physiol Biochem, 2013, 32(6):1857-1866. [6] 李健, 陈天萌, 曹剑, 等. 上调血红素氧合酶1对糖尿病心肌梗死大鼠心功能的远期影响[J]. 中国应用生理学杂志, 2014, 30(5):421-426. [7] van den Borne SW, Cleutjens JP, Hanemaaijer R, et al:Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction[J]. Cardiovasc Pathol, 2009, 18(1):37-43. [8] Moshal KS, Rodriguez WE, Sen U, et al:Targeted deletion of MMP-9 attenuates myocardial contractile dysfunction in heart failure[J]. Physiol Res, 2008, 57(3):379-384. [9] 苗婕, 孟凡鹏, 毛士云, 等. ZFP580对大鼠心肌缺血/再灌注后心室重塑的影响[J]. 中国应用生理学杂志, 2017, 33(3):262-266. [10] 卢彦珍, 王佳, 宋娟, 等. 缺血后处理对缺血/再灌注大鼠心肌基质金属蛋白酶-2表达的影响[J]. 中国应用生理学杂志, 2014, 30(1):81-84. |